Processing

Please wait...

Settings

Settings

Goto Application

1. WO2007142118 - COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT

Publication Number WO/2007/142118
Publication Date 13.12.2007
International Application No. PCT/JP2007/061099
International Filing Date 31.05.2007
IPC
A61K 31/232 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
23of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232having three or more double bonds, e.g. etretinate
A61K 45/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A61P 3/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
A61P 3/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
06Antihyperlipidemics
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
CPC
A61K 2300/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
2300Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
A61K 31/202
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
20having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
202having three or more double bonds, e.g. linolenic
A61K 31/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
A61K 31/225
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
225Polycarboxylic acids
A61K 31/232
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
23of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232having three or more double bonds, e.g. etretinate
A61K 31/351
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
351not condensed with another ring
Applicants
  • 持田製薬株式会社 MOCHIDA PHARMACEUTICAL CO., LTD. [JP]/[JP] (AllExceptUS)
  • 横山 光宏 YOKOYAMA, Mitsuhiro [JP]/[JP] (UsOnly)
  • 折笠 秀樹 ORIGASA, Hideki [JP]/[JP] (UsOnly)
  • 松▲崎▼ 益▲徳▼ MATSUZAKI, Masunori [JP]/[JP] (UsOnly)
  • 松澤 佑次 MATSUZAWA, Yuji [JP]/[JP] (UsOnly)
  • 齋藤 康 SAITO, Yasushi [JP]/[JP] (UsOnly)
Inventors
  • 横山 光宏 YOKOYAMA, Mitsuhiro
  • 折笠 秀樹 ORIGASA, Hideki
  • 松▲崎▼ 益▲徳▼ MATSUZAKI, Masunori
  • 松澤 佑次 MATSUZAWA, Yuji
  • 齋藤 康 SAITO, Yasushi
Agents
  • 渡辺 望稔 WATANABE, Mochitoshi
Priority Data
2006-15274031.05.2006JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT
(FR) COMPOSITION DESTINÉE À PRÉVENIR UN ÉVÉNEMENT CARDIOVASCULAIRE CHEZ UN PATIENT À RISQUES MULTIPLES
(JA) 多重リスク患者の心血管イベント発症予防用組成物
Abstract
(EN)
Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with HMG-CoA RI or a cardiovascular event occurring in a multiple risk patient.
(FR)
L'invention concerne une composition qui se révèle utile pour la prévention d'un événement cardiovasculaire, en particulier une composition qui est supposée produire un effet prophylactique sur un événement cardiovasculaire susceptible de survenir chez un patient souffrant d'hypercholestérolémie en dépit d'un traitement par HMG-CoA RI, ou sur un événement cardiovasculaire susceptible de survenir chez un patient à risques multiples.
(JA)
 心血管イベントの発症予防に有用で、特に、高コレステロール血症患者でHMG-CoA RIによる治療を行なったにもかかわらず発症する心血管イベント、あるいは特に多重リスク患者における心血管イベントの予防効果が期待される心血管イベントの発症予防用組成物を提供する。
Latest bibliographic data on file with the International Bureau